ELV

UnitedHealth (UNH) has turned its profits around. Operating earnings rose 55% in the second quarter of 2026, and management raised its full-year adjusted earnings guide to $19.50 to $20 a share. Revenue, though, has nearly stopped growing. So the rest of the recovery rests on something the company only partly controls: the medical bills of the people it insures.

A task force led by Vance is set to remove 760,000 alleged fraudulent Obamacare enrollments.

Harris Associates’ Q2 2026 13F portfolio grew to $75.42B, with 30 core positions over 1.25% each.

Weekly dividend updates list changes for Champions, Contenders, and Challengers, including ex-dividend and pay dates.

CVS Health (CVS) keeps a little over a penny of profit from every dollar it takes in. A net margin of 1.2% reads like a verdict on the business. On $415.1 billion of revenue, one point of net margin is worth over $4 billion, and 1.2% is closer to a floor than a peak. Management has been working on it through 2026.

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.